biotechnology enables the production of a variety of enzymes, pharmaceuticals, fuels, foods, and chemical building blocks. However, due to the high intrinsic complexity of metabolic networks, the development of new robust microbial cell factories is laborious and time-consuming. Therefore, new engineering tools are required that can accelerate the classic design-build-test-learn cycle and, consequently, strain and product development [103, 167] . Recent technological advances, e.g., multiplex genome engineering and degenerate gene synthesis, already instigate the design and construction of libraries of billions of cellular variants producing an ever expanding array of chemicals and enzymes [122] . Nevertheless, screening and selecting the optimal phenotypes from these libraries as well as dynamically controlling and quantifying the in vivo synthesis of these compounds remain tedious and a main bottleneck in the biological engineering cycle [41, 44, 103, 122, 163] .
Introduction
By unravelling and rewiring the metabolism of living organisms through metabolic engineering, industrial 1 3 transcriptional biosensors. In this context, we also refer to the advances in the field of CRISPR-based activation and repression for biosensor circuit development [11, 34, 156, 159, 171] . These biosensors are typically constructed to perform one of three functions depending on what genes the biosensor circuit controls: optical readouts through, e.g., fluorescent protein expression, dynamic pathway control through, e.g., biosynthetic pathway regulation and selection strategies through, e.g., antibiotic resistance regulation [83] .
This set of applications brings forth an enormous surge in high-throughput metabolic engineering capacity, closing the gap between generating genetic diversity and, subsequently, screening, selecting, quantifying and controlling these biological libraries [44] . Ideally, transcriptional biosensors can be designed to gratify any predefined response curve and any small-molecule specificity, i.e., the two fundamental characteristics defining a biosensor. However, like all biological systems, transcription factor-promoter pairs have evolved to fulfill a specific regulatory function in their native metabolic network. Despite the great potential of transcriptional biosensors, the lack of biosensor engineering principles currently limits their versatility necessary in metabolic engineering. Preceded by an overview of the basic architecture and regulatory mechanisms of transcriptional biosensors, this review focuses on the current efforts and future concepts that enable the engineering of a biosensor's ligand specificity, on the one hand, and engineering a biosensor's response curve, on the other hand. Prokaryotic single input/single output biosensor circuits are the main subject of this review, as these are the most implemented biological circuits for biosensor design due to their modularity.
Transcriptional biosensors: a beginner's guide
A transcriptional biosensor consists of the following: (1) a transcription factor (TF) that, preferentially specifically detects a ligand molecule (input) with its ligand-binding domain (LBD) which results in a conformational change in its DNA-binding domain (DBD), (2) a transcription factor binding site (TFBS) on the DNA level, on which the TF binds, modulating RNA polymerase (RNAP)-promoter association, which, in turn, initiates transcription of (3) an output signal of choice (see Fig. 1a ). Despite the seemingly simplistic nature of such a biological circuit, these prokaryotic one-component systems comprise more than 50 different TF families [110, 120] . Each of these TF families has differing ligand-and DNA-binding domains and, consequently, demonstrates, more or less, differing ligand and TFBS specificities and differing mechanisms for ligand recognition and transcriptional regulation [35, 45] . The two fundamental characteristics defining a transcriptional biosensor, from an engineering point of view, are the specificity of a TF for a certain ligand molecule and the response curve, describing the output signal in function of the ligand concentration (see Fig. 1b ). The specificity of a biosensor for a certain ligand molecule can be defined as the relative difference between the increase in output signal upon binding of this ligand in comparison with binding other potential ligand molecules from a predefined set of interest (see Fig. 1b ). Logically, it should be noted that biosensors with a broad specificity range can still be used for certain applications if none of the other potential ligand molecules are present in the cell. The input/output relation is represented by the biosensor response curve, which, in itself, is defined by three main parameters: (1) the operational range, including the half-maximal threshold; (2) the dynamic range; and (3) the sensitivity or slope of the response curve (see Fig. 1b ) [13, 14, 19, 125] . The operational range is the range of ligand concentrations over which the output signal exhibits significant changes. The half-maximal threshold is defined as the ligand concentration at which half of the maximal output signal is reached. The dynamic range is the range defined by the highest measurable output signal, or ON state, and the lowest measurable output signal, or OFF state, in correspondence with the operational range [125] . Leaky expression is observed when this OFF state already demonstrates transcriptional initiation when no ligand is present, or, in the case of repression, when this OFF state cannot be achieved for any level of ligand added [4] . The sensitivity for the ligand molecule, or slope of the response curve, is largely the result of the cooperativity of ligand binding by TFs and results in an either more digital-or more analog-like behavior of the biosensor [145] . Cooperative binding arises when, if a ligand is already bound by a TF, the further addition of ligand molecules alters the affinity of the TF for this ligand, either positively or negatively [4, 142] . This concept only applies for TFs that form di-or oligomeric complexes and bind the corresponding ligand molecule as such.
These biosensor response curves can be fit with the widely used Hill equation to provide a semi-empirical approach capable of providing insight in cooperativity and ligand affinity of the TF and operational and dynamic range characteristics [4, 63, 158] . Alternatively, thermodynamic models can be used to fit the generated response data based on probability dynamics of TF-and RNAP bindings to the DNA [13, 14] . These models can predict transcriptional regulation response for several classes of regulatory mechanisms and, vice versa, reveal underlying mechanisms for a given data set of unknown transcriptional control [13, 14] . In the following, the predominant types of TFBS, DBDs, and LBDs, found in nature, are considered. Subsequently, a concise overview is given of different underlying regulatory mechanisms of these ligand-dependent regulatory systems (see Fig. 2 ).
Transcriptional biosensor architecture

Transcription factor binding sites
TFBSs are specific DNA sequences which demonstrate an affinity for a specific TF. These binding sites can vary in length, base pair motif and position relative to the consensus core promoter and to additional TFBSs, if present. Commonly, TFBS are between 12 and 30 base pairs (bp) long and often possess an intrinsic symmetry due to homodimeric or homo-oligomeric binding of their corresponding TFs. Consequently, direct repeats and palindromic sequences (inverted repeats) are the most common TFBS structure [62] . Typically, the half-sites of direct repeats contain a spacing sequence which spans a multiplicity of one complete DNA helix turn (10.5 nucleotides, nt) to ensure that the two half-sites are located at the same helical face and, therefore, ensure optimal TF binding [120] . Similarly, TF-RNAP interaction is generally optimal when the bound TF is located at the same side of the DNA helix as the bound RNAP. Accordingly, the nucleotide spacer sequences between TFBS and core promoter, for instance, with most class I activators (see Sect. "Transcriptional regulatory mechanisms" and Fig. 2e ), also match complete helical turns (10.5 nt) [8, 62] . In addition, more complex compositions of TFBSs may occur when dealing with homo-oligomeric TFs, e.g., with transcriptional regulation through DNA looping [120] . Within a genome, several operons can be controlled by one unique TF which binds on variations of the corresponding consensus TFBS sequence upstream of the respective operon locations. This degeneracy of TFBSs enables different TF affinities and, consequently, adaptable levels of control for distinct genes [7] . An artificial distinction may be made in the location of the TFBSs, being situated either at the core promoter (proximal, between −60 and +60 relative to the transcription start site, TSS) or up-or downstream of the core promoter (remote, outside −60 or +60). From an engineering point of view, this distinction is of importance when applying mutagenesis techniques to specifically target either the core promoter, TFBSs or both (see Sects. "Engineering biosensor ligand specificity" and "Engineering the biosensor response curve"). Notably, binding sites as distant as −243 bp have been reported [166] .
DNA-binding domains
The DBD of a TF specifically binds with a corresponding TFBS through non-covalent interactions between the protein side chains and the exposed base pairs within the DNA grooves [17] . It should be noted that TFs with structurally similar DBD motifs may demonstrate different mechanisms of DNA binding, as observed with different members of the TetR family [35] . In addition, within a specific TF family, the position of the DBD in the protein is usually conserved, whereas across different TF families, the DBD may vary from an N-terminal, over a central, to a C-terminal position. The position of the DBD is correlated with the mechanism of transcriptional regulation for that particular TF/TFBS pair. As such, N-terminal DBDs are mostly observed in repressors, whereas C-terminal DBDs are mostly observed in activators [35, 111] . Despite this trend, there is no apparent functional reason for the relation between DBD location and the TF being either an activator or a repressor, which suggests evolutionary motives. In addition, the large LysR family demonstrates both activating and repressing mechanisms while having a clear, conserved N-terminal DBD [111] . The majority of DBDs has one of three basic protein motifs, with the winged helixturn-helix (HTH) motif the most commonly observed [45, 110] . First, the canonical HTH motif, consists of three helices in an open configuration with the characteristic turn between the second helix, which has a stabilizing function, and the third helix, which recognizes the TFBS in the major DNA groove [5, 17] . Noteworthy, the HTH motif is not stable as a stand-alone protein domain and, therefore, is always part of a larger DBD to enable proper functionality. Furthermore, TFBS recognition can also occur by interacting with other regions of the DBD [106] . Second, the winged HTH motif (wHTH) comprises an elaboration on the classic HTH motif with the addition of a β-strand hairpin unit (wing) at the C-terminus of the DBD [5] . Third, the less common ribbon-helix-helix (RHH) motif uses a β-sheet, instead of the classic α-helix, to interact with the TFBS [45, 135] .
Ligand-binding domains
The LBD of a TF enables small-molecule dependency of transcriptional regulation through the conformational transduction of the ligand-binding input signal. This signal is transmitted either to the DBD, to alter DNA binding, or, in some cases, to an RNAP-activating domain, to alter RNAP recruitment, accordingly [45] . TFs bind a wide variety of ligand molecules ranging from amino-acids, over sugars, metal ions, fatty acids and aromatic to terpenoids, flavonoids and antibiotics, among others [35, 44, 45, 109, 125] . In contrast to the highly conserved DBDs, LBDs bear a great diversity in amino acid sequence due to the immense array of chemical structures of possible ligands. Correspondingly, prediction of domain structure, let alone prediction of potential ligands, based on existing structures, remains difficult [78] . Besides a ligand-binding functionality, many TFs possess dimerization domains and some RNAP-activating domains, whether or not as a part of the LBD. In addition to direct TF-RNAP protein-protein interactions for transcriptional activation, some activators, such as members of the XylR/NtrC family, are ATP dependent and contain the AAA+ fold for ATPase activity [118] . Upon ligand binding, this functionality provides energy for the TF to reconfigure RNAP into an open conformation which, subsequently, initiates transcription [23, 161] . The majority of TFs form homodimeric or homo-oligomeric complexes to bind their respective palindromic TFBSs with each an HTH domain per monomer [45, 62] . These TFs contain a protein dimerization interface to interact with additional TF copies to achieve cooperativity which is of great importance for the sigmoid nature of the biosensor curve [120] .
Transcriptional regulatory mechanisms
One-component regulatory systems generally modulate transcription via three basic mechanisms. These mechanisms result either in activation or in repression of transcription by interfering directly or indirectly with the protein/DNA interaction of the RNA polymerase (RNAP) and the core promoter sequence (see Fig. 2 ). In a first mechanism, TFs create conformational changes in the DNA itself either by looping it, making the promoter inaccessible for RNAP (see Fig. 2a ), or reorienting the −35 and −10 consensus boxes, by twisting the DNA helix, for improved accessibility by RNAP (see Fig. 2b ). In a second mechanism, exclusive to repression, TFs structurally hinder transcription either by sterically hindering the binding of RNAP to the core promoter (see Fig. 2d ) or by binding at the start codon and, consequently, blocking transcription elongation as a roadblock mechanism (see Fig. 2c ). The third mechanism, exclusive to activation, involves the recruitment of RNAP either by interacting with the α-subunit (αCTD) of RNAP (class I activation, see Fig. 2e ) or by promoting directly the binding of the σ-subunit of RNAP to the promoter (class II activation, see Fig. 2f ) [20, 62] . Class I activators bind to TFBSs upstream of the core promoter, while Class II activators bind at the −35 consensus box [21] . Each of these three basic mechanisms can be subdivided into two distinct modes of regulation based on the position of the TF/TFBS pair relative to the core promoter/RNAP pair (see Fig. 2 ). As mentioned earlier, TFBSs may be considered to be located either at the core promoter (proximal, see Fig. 2b , d, f) or located up-or downstream from the core promoter (remote, see Fig. 2a , c, e), for engineering purposes.
Some TFs are exclusively activators, such as LuxR, or exclusively repressors, such as LacI and TetR, while others demonstrate both functionalities depending on the target TFBSs at specific promoters, such as LysR [109, 110, 147] . Interestingly, in Escherichia coli (E. coli), these dual regulators account for almost 40% of all TFs. In addition, some TFs, such as AraC, are bound to the TFBS in the absence of the ligand molecule, repressing transcription initiation, which is relieved upon ligand binding [147] . These systems may offer a more stringent level of control with high induction ratios [55, 147] .
From an engineering point of view, these six modes of regulation are of great importance to determine, on the one hand, the boundaries and, on the other hand, the degrees of freedom of the biosensor design space. Biosensor characteristics, such as spacing between multiple TFBS copies, distance from TFBS to the core promoter, TF-TFBS and TF-RNAP affinities, among many others, are all aspects that either create engineering opportunities or set strict boundaries for biosensor functionality.
Classification and mining of biosensor parts
TFs, the key components in biosensors, are classified based on amino acid sequence conservation of their DBD and identified by homology-based predictions using Hidden Markov Model (HMM) profiles from databases, such as DBD, Superfamily, and Pfam [46, 110, 120, 164, 165] . For instance, the complete set of 304 TFs in E. coli was classified into 78 evolutionary families each demonstrating a variable number of members and regulatory mechanisms [112] . Notably, the LysR family is the largest known family in bacteria, followed by the AraC-and TetR families [120] . Furthermore, the abundance of each of the TF families varies in different organisms [120] . A more detailed overview of the TF families and their characteristics is reviewed elsewhere [45, 106, 110, 112, 120] .
Moreover, a growing number of databases are available which contain experimental information on TFs, the genes they regulate and their TFBSs, in addition to genomewide predictions of TFBSs, TFs, and regulons [120] . For instance, while RegulonDB [49] and EcoCyc [74] provide a specific information on transcriptional regulation in E. coli, DBD [164] , RegTransBase [30] and Prodoric [53] provide regulatory information on prokaryotes in general [62, 120] . In addition, a part database, PAMDB, was recently created which comprises data from 135 publications containing a total of 118 characterized biological circuits and 165 genetic parts in E. coli [66] . The availability of reported and predicted TF/TFBS pairs to detect specific ligands is critical in the development of novel biosensors. Consequently, several in silico, in vitro, and in vivo mining strategies were developed to find the correct TF for a ligand and, accordingly, find the matching TFBS for a TF.
With the aim of identifying a TF for a specific ligand, databases are available which contain information that specifically links ligand molecules with their corresponding prokaryotic TF, i.e., RegPrecise [105] , RegulonDB [49] , RegTransBase [30] , and BioNemo [22] . Despite the fact that these databases are great tools in this search, they are still limited to the scarce ligand-TF interactions reported in the literature. Recently, a web-based tool, SensiPath, was created, which combines these databases with additional databases containing enzymatic reactions and chemical structure libraries [39] . This tool enlarges the known set of detectable compounds by screening for enzymatic transformations that convert non-detectable compounds into detectable ones, also dubbed Sensing-Enabling Metabolic Pathways (SEMPs) [80] . The concept of SEMPs was substantiated in several studies, creating indirect biosensors for lindane, toluene, salicylaldehyde, 3-hydroxypropionate, organophosphorous compounds, cocaine, hippuric acid, parathion, nitroglycerin and 2-chloro-4-nitrophenol [28, 81, 99, 123, 139, 170] . On the other hand, to relinquish the dependence on prior research for TF discovery, SubstrateInduced Gene Expression Screening (SIGEX) enables the screening of metagenomes for substrate-induced gene expression and can be used to identify TFs, in addition to catabolic genes [153] . Using this method with benzoate as induction substrate, 58 positive clones were obtained, from which both TFs as well as catabolic genes could be identified [153] .
From the TFBS perspective, the growing field of transcriptome analysis provides the necessary high-throughput tools to discover TFBS/TF interactions, e.g., DNA microarrays, mRNA sequencing and chromatin immunoprecipitation (ChIP) (discussed in more detail elsewhere, [36, 62, 72, 82, 114, 120, 140, 160] ). In general, transcriptome comparisons between wild-type and TF knockout strains are used to identify TF/TFBS pairs [62] . A different approach on whole-genome transcript arrays was used to search for a farnesyl pyrophosphate-responsive (FPP, an isoprenoid precursor) promoter [36] . Here, the toxicity of FPP in E. coli was exploited to screen for FPP-responsive promoters based on the transcriptome differences between two strains, either expressing an FPP-catabolic enzyme or a noncatalytic variant. The identified promoters were used for dynamic control of the amorphadiene biosynthesis pathway with a doubling of microbial production as a result [36] . In a recent study, the Alon library, comprising circa 2000 different E. coli promoter-gfpmut2 fusions [172] , was used to screen and select for galactose-responsive and l-phenylalanine-responsive promoters by toggled fluorescence-activated cell sorting (FACS) [91] . Based on the literature, the corresponding TF was identified for an identified l-phenylalanine-responsive and, subsequently, used for the creation of a biosensor to successfully screen a mutant library for enhanced l-phenylalanine production [91] . Finally, TFBSs can also be predicted using several computational methods which use sets of DNA sequences, reported to be regulated by a certain TF, to generate TFBS motifs (reviewed in more detail elsewhere, [62, 120] ). Subsequently, these motifs can be used to scan genomes for putative TFBSs to further expand the TF-TFBS repertoire [42, 62, 94, 120, 143, 151] .
Biosensor applications for optimizing microbial cell factories
Transcriptional biosensors are used mainly to perform one of three key functions in the development and optimization of microbial production strains with industrial significance, namely, high-throughput screening, adaptive laboratory evolution and dynamic pathway control [44, 83, 92, 115, 125, 131, 163, 175, 176] . These three key biosensor functionalities are exemplified in the following. For a more detailed overview of these biosensor applications, the reader is referred elsewhere [83, 92, 163] .
High-throughput screening
Biosensors controlling the expression of an easily screenable output, e.g., a fluorescent protein, enable high-throughput screening of mutant libraries to select for the desired phenotypes [83] . These biosensors can be used to directly quantify the intracellular or extracellular concentration of the corresponding ligand molecule, without the need for labor-intensive analysis techniques, such as gas or highperformance liquid chromatography (GC and HPLC) [41, 83] . Recently, different biosensors were developed to enable the real-time monitoring of the microbial production of 3-hydroxypropionate (3HP), acrylate, glucarate and muconate [123, 124] . In addition, several process parameters in the microbial production of 3HP were optimized using this biosensor, resulting in a 23-fold increase in production [123] . This concept of biosensor-driven high-throughput screening was also applied to screen enzymes for their capacity to degrade lignin [90] . To this end, a biosensor was developed which detects several lignin degradation products, such as ferulic acid, p-coumaric acid, and sinapic acid [90] . In a different study, an NADPH-responsive biosensor was developed to screen an alcohol dehydrogenase mutant library using FACS [138] . Here, an improved alcohol dehydrogenase variant, with an eightfold improved K M value for its substrate 4-methyl-2-pentanone, was selected [138] . Furthermore, biosensor-driven FACS for high-throughput screening of mutant enzyme libraries was also successfully used to identify improved mutant enzymes for lysine and histidine biosynthesis [12, 132] .
Adaptive laboratory evolution
Besides, biosensors can be used to control the expression of a selection marker to enrich mutant libraries with phenotypes demonstrating the desired traits. Usually, a toggled selection workflow is implemented to eliminate evolutionary escapees. This workflow typically comprises the iteration of, first, a negative selection, second, the induction of the biosynthetic pathway, and third, positive selection for the desired phenotype [115] . Such an approach was applied to the increase microbial production of naringenin and glucaric acid by 36-and 22-fold, respectively [115] . To this end, biosensors controlling the expression of a dual selector gene were developed, optimized to reduce the evolutionary escape rate, and finally, applied in up to four rounds of directed evolution with toggled selection [115] . A different approach was pursued by Chou and Keasling who developed both a tyrosine-and isopentenyl diphosphate (IPP)-responsive biosensors to directly control the expression of a mutator gene, and as such the mutation rate [29] . This adaptive laboratory evolution workflow improved tyrosine and IPP biosynthesis up to fivefold and threefold, respectively, and led to the identification of several genes affecting these metabolite pools [29] . Furthermore, instead of using specific selector genes under the control of the biosensor of choice, a biosensor controlling the expression of a fluorescent protein was used in combination with FACS to develop an adaptive laboratory evolution workflow applying an artificial selective pressure [93] . This method enabled the identification of several l-valine producing Corynebacterium glutamicum variants demonstrating higher growth rates and increased titers and a three-to fourfold reduction of by-product formation [93] . A recent study demonstrated the use of biosensors to dynamically control the cell population to increase the fraction of highperforming nongenetic variants, consequently, improving the overall performance of the population [169] . This approach rewards high-performing cells in a population with a competitive advantage in cell growth as the biosensor output, e.g., tetracycline resistance or the expression of an essential gene. For example, this method was applied to tyrosine and fatty acid production which improved both threefold [169] .
Dynamic pathway control
Genetic circuits can be constructed using biosensors which control the biosynthetic pathway of interest, thus enabling dynamic control [102] . For example, dynamic control of a biosynthetic pathway enables the fine-tuning of enzyme activity in accordance with the level of ligand present to counteract the toxic accumulation of the ligand [83] . This concept was applied to dynamically control the biosynthesis of fatty acids in E. coli for biodiesel production through the use of a newly developed fatty acid/acyl-CoA-responsive biosensor [174] . The fatty acid ethyl ester (FAEE) biosynthetic pathway was divided into three modules of which FadR, the transcription factor of choice, inhibited two modules which form by-products. This inhibition is relieved when fatty acids, which bind FadR, accumulate, as such increasing FAEE production. This dynamic pathway regulation increased production threefold to 28% of the theoretical maximum [174] . A similar approach was used to dynamically control fatty acid production by constructing a FapR-based malonyl-CoA-responsive biosensor which exercises a negative feedback on the biosynthetic pathway [84] . Here, it was demonstrated that this regulatory effect increased the fatty acid titer and productivity by 34% and 33%, respectively [84] .
Engineering biosensor ligand specificity
Biosensor-driven metabolic engineering is only feasible if a TF is available which specifically detects the target molecule in a complex metabolic network without significant interference of other compounds. Therefore, as an alternative to exploring nature for existing TFs, characterized TFs can be engineered to create custom specificity for the ligand of choice. In addition, biological engineers aspire the microbial production and detection of a vast array of natural compounds, whether or not native to the host's metabolism, and even new-to-nature compounds. Consequently, the creation of custom ligand specificities for known TFs is a critical bottleneck in biosensor development. In the following, the four main strategies to overcome this hurdle are described (see Fig. 3 ), ranging from the least to the most foreknowledge-dependent methods. First, random mutagenesis methods are discussed, followed by structure-based site-directed mutagenesis methods. Next, the creation of chimeric TFs is explained. Finally, the currently applied computational tools are discussed.
Random mutagenesis methods
Randomly mutating a TF, or parts of it, can generate mutant TF libraries which can be screened for TF variants responsive to a non-natural ligand of interest. However, completely shifting the specificity of a TF from its natural ligand molecule to a novel ligand of choice is not a straightforward process, even if both molecules have similar structures [47] . Parallel to other ligand-binding proteins, a TF is likely to mutate into a more promiscuous, ancestral TF form as a first step towards the divergence of a novel specificity [1, 48, 67, 87] . Screening mutant TF libraries for custom specificity consistently gives rise to these ancestral TFs which have a broader specificity range, incorporating the non-natural ligand of choice, rather than a complete switch in specificity. However, these mutant TFs can be further matured towards the true ligand specificity of choice using more comprehensive mutational strategies [1, 48, 70, 87, 150] . Random mutagenesis methods for TF engineering, which generally create TF variants with a broadening in specificity range, can be applied either on the complete TF amino acid sequence or on the LBD (see Fig. 3a ). Targeting the complete TF sequence can reveal unexpected mutational hotspots, while targeting only the LBD may ensure the preservation of the natural DNA-binding efficiency potentially resulting in higher mutational success rates.
For example, the complete amino acid sequence of the quorum-sensing LuxR TF from Vibrio fischeri was targeted by error-prone PCR (epPCR) and DNA shuffling techniques to examine and alter the acyl-homoserine lactone (acyl-HSL) specificity and sensitivity [31] . Using this workflow, LuxR variants were generated that responded to a broader range of acyl-HSLs while retaining the sensitivity for the natural ligand molecule [31] . This study was expanded with a modified positive/negative screening method to eliminate mutant LuxR variants which still responded to the natural ligand molecules, consequently, narrowing down the specificity range to wanted ligand compounds only [32] . Here, random mutagenesis was applied on the N-terminal LBD, which enabled the creation of true custom ligand specificity by tipping the balance to an increased sensitivity for straight-chain acyl-HSLs while diminishing the sensitivity for unwanted compounds [32] . The flexibility of customizing the specificity of the LuxR TF was also validated through directed evolution of the complete TF for short-chain acyl-HSLs [56] . In a different study, the complete TF sequence of the alkane-responsive AlkSp TF from Pseudomonas putida was targeted for directed evolution-based random mutagenesis to modulate its broad specificity. Mutant TFs were successfully generated from which a biosensor was developed for specific short-chain alkane detection [119] .
Instead of targeting the complete TF sequence, the C-terminal LBD of NahR, a LysR-type salicylate-responsive TF, was randomly mutated to generate TF variants with altered specificity for different aromatic compounds, in particular benzoate [24] . From this mutational library, several mutant TFs were isolated with novel specificity profiles, such as augmented benzoate and salicylamide specificity, in addition to augmented overall sensitivity. Interestingly, these specific changes were mostly due to single amino acid substitutions which may indicate the importance of these residues in ligand recognition of NahR [24] . A similar approach was undertaken to successfully enhance the sensitivity for and broaden the specificity range for 11 phenolic ligand compounds for a DmpR-based pollutant biosensor [168] . In a different study, an XylR mutant library was screened for enhanced DNT responsiveness to understand how TFs acquire novel specificities [48] . Here, both the linker and the LBD were targeted for mutagenesis. The resulting DNT-responsive mutants retained their sensitivity for their natural ligands and demonstrated a broadening in ligand specificity. Interestingly, all amino acid substitutions were located outside the binding pocket of the LBD, within protein regions responsible for conformational signal transduction to the DBD upon ligand binding [48] . Similarly, directed evolution was used by Lönneborg and coworkers to evolve the salicylate-responsive LysR-type DntR regulator to a 2,4-dinitrotoluene (DNT)-specific variant [85] . Through directed evolution, both the linker and LBD of the TF were randomly mutated, followed by the recombination of previously gained mutations which resulted in several DntR variants with a greatly improved response for DNT and other aromatic compounds [85] . Finally, the specificity of TetR was successfully shifted from tetracycline to a tetracycline analog by four rounds of in vitro directed evolution through mutagenesis of the non-DBD parts of the TF [134] . Amino acid substitutions in the extended ligandbinding pocket were discovered which are determinative in the flexibility of ligand binding in TetR [134] .
Structure-based site-directed mutagenesis methods
When the crystal structure of a TF and its ligand-binding pocket is available, site-saturation and site-directed mutagenesis can be used to target specific residues which interact directly with the ligand molecule (see Fig. 3b ). As such, random or rational substitutions of specific aminoacids can optimize a binding pocket to bind a novel ligand with differing functional groups in comparison with natural ligands. For instance, site-saturation mutagenesis was used to target a small set of five specific amino-acid positions in the ligand-binding pocket of the L-arabinose-responsive AraC TF from E. coli [147] . A positive/negative screening method, accelerated by FACS, was used to successfully select mutant TFs for D-arabinose induction. Although these mutant TFs did not respond to other sugars, adding multiple decoy ligands in the negative screening step could ensure the desired custom specificity in future engineering experiments. In parallel, an additional mutant library was created for the same purpose by epPCR on the LBD sequence of AraC. Despite the creation of D-arabinoseresponsive mutants, these mutants did not demonstrate inducibility to the same extent as the mutants spawned by the site-directed approach [147] . In an ensuing study, it was demonstrated that the level of sensitivity, when engineering AraC for altered ligand specificity, can be fine-tuned by introducing mutations in the N-terminal arm of AraC [149] . Moreover, in three additional studies, the same AraC TF was redesigned, through site-directed mutagenesis and FACS-mediated dual screening, for mevalonate, triacetic acid lactone, and ectoine responsiveness, respectively [27, 146, 148] . From each novel AraC variant, a biosensor was constructed and applied in the high-throughput screening of biosynthetic pathway libraries, producing their respective ligand molecules, to successfully select for improved microbial production [27, 146, 148] . A similar approach was employed to redesign a previously developed TetR variant [134] to narrow down its newly gained broader specificity [61] . Using site-saturation mutagenesis to target specific residues in the ligand-binding pocket, the sensitivity for other ligand molecules was successfully reduced while maintaining the sensitivity for the ligand of choice, thus increasing genuine specificity [61] . Furthermore, site-saturation mutagenesis was used to target the linker region of the previously discussed TetR variant to demonstrate long-range mutational effects on DNA binding, signal transduction, ligand binding, and specificity [60, 61] . A more rational structure-based mutagenesis approach was used to alter the specificity of the quorum-sensing LuxRtype, TraR TF. Four amino-acid positions were identified by ligand docking to be critical in the formation of hydrogen bonds with the natural ligand molecule, an acyl-HSL. By substituting these residues with specific amino-acids, mutant TFs were created which demonstrated an increased specificity for acyl-HSLs with either a different 3-oxo substituent group or a shorter acyl-substituent chain [25] .
The success of these purely structure-based techniques, to identify specificity-determining residues, can be improved by comparing existing orthologous and paralogous TFs [98] . This concept enabled the identification of several amino-acid positions in LacI, critical for both DNAand ligand binding. Interestingly, these identified aminoacids constitute only a small fraction of all residues at these binding interfaces which accentuates the difficulty of determining critical residues with random or structure-based mutagenesis [98] . In a recent study, an analogous approach was applied to engineer MopR, a TF from the NtrC family, for a broader specificity range [118] . As such, the nonnatural ligand, 2,5-dimetylphenol, which is a natural ligand for the TF DmpR of the same family, was included in the specificity range of MopR. This was accomplished by substituting two amino-acids in the ligand-binding pocket of MopR for the two corresponding amino-acids from the ligand-binding pocket of DmpR, consequently mimicking its binding region [118] .
Chimeric transcription factors
Chimeric TFs can be created by recombining DBDs and LBDs from different homo-or even heterologous proteins to generate new combinations of reported functionalities (see Fig. 3d ). Concurrently, new insights can be gained in inter-domain contacts and functional contributions of non-conserved TF regions [95, 96] . The advantage of this technique is that, from a holistic point of view, domain recombination is not expected to change the functionality of an independent domain. Therefore, chimeragenesis increases the predictability of novel TF designs by permitting the recombination of, for example, DBDs with highly characterized DNA-binding dynamics with nonnative LBDs to create new ligand specificities in a given biosensor framework, or vice versa [116] . From an atomistic view, chimeric TFs, with non-conserved amino-acids at the interface of LBD and DBD, could acquire different inter-domain interactions and, consequently, different functionalities. As such, amino acid substitutions in these nonconserved interfaces provide additional engineering opportunities for fine-tuning TFs [95, 96] .
More than a decade ago, an XylR combinatorial/mutant library was created by shuffling LBDs originating from the homologous XylR, DmpR, and TbuT proteins, each responding to a specific set of ligand molecules [51] . Besides the native LBD coding sequences, additional single mutations were introduced into these LBDs to further increase the library size. Subsequently, this library was screened for TF variants that responded to four different non-native aromatic ligands. For each of these four molecules, TF variants could be isolated showing a clear response upon ligand addition. These novel ligand specificities were acquired by abolishing possible signal transduction constraints through chimeragenesis, by modulating the binding pocket through mutagenesis or by a combination of both [51] . A similar workflow was applied to create a specific 1,2,4-trichlorobenzene-responsive XylR variant for the development of a γ-hexachlorocyclohexane biosensor in combination with an SEMP (see earlier) [99] .
More recently, a synthetic library of chimeric LacI/ GalR transcriptional regulators was created by joining the LacI DBD and corresponding linker sequence to nine different LBDs from the same TF family, each binding different sugar or purine molecules [95, 96, 152] . This research demonstrated that chimeric LacI/GalR TFs retained the native ligand specificity of the respective LBD despite "mismatched" DBD-LBD interfaces, which is of great interest for chimeric biosensor design. Even the mode of transcriptional regulation was preserved, be it either activation or repression. Second, the non-conserved linker positions were targeted for mutagenesis to investigate their sequence-function relationship. These inter-domain positions displayed a significant functional importance and could be used to fine-tune repression levels. Finally, the tetramerization functionality of the wild-type LacI, which is absent in these chimeras, was mimicked by repeating the TFBSs to mediate dimer-dimer interactions. This TFBS repetition and the corresponding inter-operator spacing are additional parameters that enhance the flexibility of biosensor design [95] . This family of nine ligand-specific chimeric LacI/GalR TFs was used to build several multi-input transcriptional logic gates based on the concept that they have the same DBD, and thus bind to the same TFBS, but have a different ligand molecule as input [137] .
A broader concept of chimeric modularity was implemented by Chou and Keasling to generate a synthetic TF for the isoprenoid precursor, isopentenyl diphosphate (IPP) [29] . This chimeric TF consists of three parts: (1) an enzyme that binds the ligand of choice; (2) a linker that transduces the ligand-binding signal of the enzyme part to (3) the DBD that responds to this signal by regulating RNA polymerase binding. For this, the native arabinose-responsive C-terminal LBD of the known AraC TF was replaced by an IPP isomerase, Idi, chosen for its ability to dimerize upon IPP binding. In contrast to the activating mechanism of the wild-type AraC, this chimeric TF represses transcription when IPP is supplemented. To further enhance the biosensor response dynamics (see Sect. "Engineering the biosensor response curve"), different IPP sensors were created by applying epPCR on the former chimeric TF. One of these synthetic TFs was used as part of an IPP-biosensor circuit that adaptively controlled the mutation rate in a lycopene producing strain through a feedback-regulated evolution of phenotype (FREP) system. In this way, the mutation rate and fluorescent protein production were increased if low levels of IPP were detected by the biosensor. As such, phenotypes were directed to and selected for IPP accumulation based on fluorescence with a twofold increase in production as a result [29] .
Computer-aided design
Computational methods can aid the de novo design of ligand-binding pockets for custom specificity by sampling from a significantly larger in silico mutagenic space (~10 76 ) in comparison with directed evolution-based mutagenesis methods (~10 14 ) [41, 47, 70, 86] . Consequently, the TF test space is reduced leading to a more efficient screening workflow and a more valuable mutational data set to aid future TF engineering attempts. In addition, although random and structure-based site-directed mutagenesis can generate custom specificities for novel ligand molecules similar to the natural ligands (see earlier), these methods are still constrained by the structural characteristics of the native binding pocket [47, 70, 86] . Therefore, computational protein design may be favorable for the creation of custom specificities for ligand molecules dissimilar to the natural ligand molecule (see Fig. 3c ) [150] . Once a TF variant has acquired a sensitivity for such a novel dissimilar ligand molecule, the specificity may be further matured by additional mutational and computational techniques [88] .
For example, a combination of several computational tools was used to redesign the LBD of a 4-hydroxybenzoate-responsive TF, PobR, to create a TF variant with a shift in specificity towards the non-natural ligand, 3,4-dihydroxybenzoate [68] . This workflow circumvented the need for a reported crystal structure of this specific TF, by applying Rosetta-based comparative modeling at the LBD level [37] . As a method for computational library design, a compromise could be made between targeting a small set of rational substitutions, on the one hand, and constructing an unwieldy large random mutagenesis library, on the other hand. As such, Rosetta-based ligand docking was used, from which a mutational library of every critical Rosettaidentified position was created [33] . Besides successfully altering the specificity of this TF, a rich data set was created of non-random mutations which can provide insights for future TF engineering attempts and for scrutinizing Rosetta-based models [68] .
Computational protein design in combination with a cell-free transcription-translation (TX-TL) preliminary screening method was used to create mutational variants of the TetR-family TF, QacR, with novel ligand specificities [88] . To demonstrate the power of computational methods, the ligand of interest, vanillin, and the TF, QacR, were chosen independently from one another whereby this ligand is dissimilar in structure to the natural ligand molecules of QacR. Potential vanillin ligand-binding sites were predicted based on the crystal structure of QacR using Phoenix Match [77] from which multiple critical amino-acid positions were selected and 17 mutant sequences were computationally generated containing a variable number of specific amino acid substitutions [2, 77] . After in vitro and subsequent in vivo screening, mutants could be isolated which demonstrated an increased sensitivity for vanillin. Although further TF optimization would be preferential for biosensor application, these mutants are valuable mutational starting points which probably could not have been obtained with classic directed evolution techniques. Although the potential toxicity of mutant TFs is not accounted for, the cell-free screening method applied in [88] is a fast and reliable preliminary screening method which could be used for screening ligand/TF couples.
In a recent study, a combination of computational protein design, protein-wide site-saturation and random mutagenesis was used to generate novel LacI specificities for four different ligand molecules, gentiobiose, fucose, lactitol, and sucralose, with decreasing similarity to common LacI ligands [150] . To this end, Rosetta was used to successfully design LacI variants which responded to the three most dissimilar ligands and demonstrated similar inducibility to the wild-type LacI. In comparison, straightforward random mutagenesis by epPCR was applied to achieve the same goal resulting in either less responsive variants for fucose and lactitol or none at all for sucralose. However, it should be noted that comparable results as the Rosetta-based workflow could be achieved with epPCR but would require a much more labor-intensive approach. Furthermore, gentiobiose-responsive LacI variants could be identified by protein-wide single site-saturation mutagenesis and subsequent screening. This approach generated single amino acid substitutions in the binding pocket, dimerization interface or DBD which all led to a similar increase in gentiobiose-specificity, thus indicating that distant substitutions could be as potent in changing sensitivity as substitutions in the ligand-binding pocket. Finally, a combinatorial mutational shuffling approach was successfully used to decrease the sensitivity for IPTG while further increasing the newly gained sensitivity for the novel ligands to mature true specificity for these novel ligands [150] .
Engineering the biosensor response curve
Transcriptional biosensors are developed for a wide variety of specific applications [83, 91, 175, 176] each imposing specific requirements in terms of operational and dynamic ranges (see Sect. "Transcriptional biosensors: a beginner's guide"). To tune these response curve parameters, the TF, the TFBS and the core promoter, and the global biosensor architecture can be altered. Logically, different approaches are to be preferred in accordance with the regulatory mechanism, either activation or repression, and the TF family. In the following section, the state-of-the-art engineering concepts are discussed for each of these biosensor parts (see Fig. 4 ).
Engineering at the transcription factor level
The TF plays the pivotal role in any biosensor system through the direct interaction with both the ligand and the TFBSs, in addition to potential interactions with TF copies and RNAP. Hence, on the protein level, mutant TFs can be created and selected which demonstrate modified interactions, thus altering the response curve of the biosensor (see Fig. 4a ). On a more general level, the expression level of the TF relative to the number of the TFBSs can be modulated to tune these interactions in a more straightforward and predictable manner in comparison with more tedious protein and TFBS engineering techniques (see Fig. 4b ) [158] .
Creating custom transcription factor variants
Mutating the LBD of a TF can spawn TF variants with increased sensitivity for their corresponding ligand, therefore, altering the response curve (see Sect. "Engineering biosensor ligand specificity") [54, 136] . However, besides the ligand-binding affinity, also the transduction efficiency of the binding signal, the DNA-binding affinity and the dimerization efficiency influence the shape of the response curve. Consequently, TF mutagenesis methods range from random to site-directed methods, corresponding to mutational targets ranging from the complete amino acid sequence, over the DBD and non-conserved linker sequence, to specific amino-acid residues with reported functionalities (see Fig. 4a ). As mentioned previously (see Sect. "Engineering biosensor ligand specificity"), the specificity and sensitivity for a ligand molecule are two inseparable characteristics, and therefore, the applied mutagenesis techniques and their targets are predominantly similar. As such, in many studies aiming to alter the specificity of a TF, an altered overall sensitivity was also observed (see Sect. "Engineering biosensor ligand specificity") [24, 31, 48, 85, 168] .
For example, the prevalent LacI repression system was subjected to a directed evolution study, covering the complete amino acid sequence, to increase ligand sensitivity at low IPTG concentrations [130] . The operational range was decreased and could be shifted towards lower IPTG concentrations, while the dynamic range could be increased through a set of mutations scattered across the different TF domains and its linker junction. Furthermore, a balance was observed between the mutational stabilization of, on the one hand, the inducer-bound form and, on the other hand, the DNA-bound form of the TF [130] . Similarly, directed evolution was performed on the complete DmpR gene to increase the maximum response signal of a biosensor for organophosphorus compounds [28] . Interestingly, instead of the LBD, the domain responsible for activating RNAP upon ligand binding appeared to be the mutational hotspot in this screening for improved dynamic range. Several mutants demonstrated the desired increase in operational and dynamic ranges but also a higher level of leaky expression in comparison with the wild-type TF. This may indicate a more semi-constitutive expression of the fluorescent reporter gene rather than an increase in sensitivity for the ligand molecule [28] . More intricately, the ligand sensitivity of a naphatalene/salicylate-biosensor was increased via rational engineering by implementing site-directed mutagenesis at the LBD and dimerization domain of this LysR-type TF, NahR [136] . Only two residues, previously identified to be involved in ligand binding, were targeted [24] . This approach created eight biosensor variants with differing operational and dynamic ranges, some of them displaying increased sensitivity (up to 50-fold) compared to the wild type [24, 136] . Furthermore, a comparable strategy was used to alter the sensitivity of the phenolic compoundresponsive TF, DmpR [54] . First, the ligand-binding pocket for phenol and similar compounds was predicted using the ligand-docking algorithm, LIGSITE [59, 65] , and a model of the N-terminal LBD domain. Second, key ligand-binding residues were identified by docking analysis and targeted for site-directed mutagenesis to successfully increase the sensitivity for these compounds [54] .
Instead of targeting the ligand-binding parts of the TF, mutagenesis of the DBD or linker region can generate TF variants with various DNA-binding affinities or signal transduction efficiencies and, accordingly, different response curves of the corresponding biosensors. As such, the HTH motif of TetR was mutated to increase its DNA-binding affinity for two different TFBSs in two different studies [57, 58] . In addition to the HTH positions in direct contact with the TFBS, other mutational sites 4 Schematic overview of the discussed engineering strategies for the customization of a biosensor's response curve. The classification of these four strategies is based on, on the one hand, the applied method, being either mutagenesis or modulation of the TF/TFBS ratio and, on the other hand, being either directed to the transcription factor (TF) or the transcription factor binding sites (TFBS). In addition, for each of these four engineering strategies, a schematic representation is depicted indicating the effects of the applied strategy on the different biosensor dynamics in this domain were involved in the augmentation of the DNA-binding affinity. These residues are probably associated with adjusting the position of the HTH motif at the target DNA [57, 58] . To investigate the long-range effects of amino acid substitutions in LacI, several mutants were created based on previously reported critical residues in the linker region [144] . These specific LacI variants exhibited differing properties, such as enhanced ligand sensitivity, TFBS affinity or even both [144] . Additional critical amino-acid residues in the non-conserved linker region of LacI were predicted to be responsible for the determination of TFBS specificity based on a statistical analysis of sequence alignments from orthologous and paralogous members of the LacI/GalR family, in combination with the previously reported critical residues [96, 144] . Subsequently, these predictions were experimentally evaluated in a LacI/GalR chimeric TF containing the wild-type DBD and linker from LacI and the LBD of GalR (LLhG). The constructed chimeric LacI variants demonstrated a variety of changed functionalities ranging from enhanced dynamic range, over altered TFBS affinity, to changed TFBS specificity which emphasizes the importance of the linker region in LacI TFs and potentially other TF families [96, 173] .
Finally, mutagenesis of the TF sequence can also be used to reverse the regulatory direction of a biosensor upon ligand binding. In this fashion, the TetR repressor was inverted to generate several revTetR variants which display higher DNA-binding affinity upon ligand binding instead of the contrary [133] . These mutations were clustered at the LBD/DBD interface although it was proven that even one amino-acid exchange was sufficient to reverse the TetR functionality [71, 133] . In a subsequent study, the sensitivity of this revTetR repression was further increased by sitedirected mutagenesis [75] .
Tuning the transcription factor expression level
The variation of the expression level of the TF, relative to the ligand concentration and the number of TFBSs, can alter the ligand/TF and TF/TFBS interplay and, consequently, the response curve of the corresponding biosensor [52] . The expression level of a TF can be tuned via, roughly, three basic approaches (see Fig. 4b ). First, the TF gene can be incorporated in an additional inducible regulatory system to enable tuning of TF expression over a continuous range [18, 158] . Second, the expression level can be varied discretely by introducing either predefined or randomized constitutive promoter and/or ribosome-binding site (RBS) libraries [3, 38, 97, 129, 158, 170] . Third, a double plasmid architecture, with the TF gene and TFBSreporter gene located on two different plasmids, permits the independent variation of TF expression level and TFBS copy number by utilizing differing origins of replication generating differing plasmid copy numbers. The same approach can be implemented by integrating either the TF gene or the TFBS-reporter gene on (multiple) chromosomal locations [6, 18, 130] . The concept of introducing competing TFBSs to titrate available TFs away from the TFBS of the biosensor will be discussed in the next section, engineering at the TFBS level.
The first two methods were used in parallel to successfully alter the response curves of three biosensors, based on the repressors TetR and ArsR and the activator LuxR [158] . The arabinose-inducible AraC regulatory system and a set of constitutive promoters (Anderson collection, Registry of Standard Biological Parts [73] ) were used to modulate the TF expression level over a continuous and discrete range, respectively. Substantiated by the parameters of the fitted Hill function, the tailored repressor-based biosensors demonstrated increased ligand sensitivity and dynamic range when the respective TFs were less abundantly expressed. As such, it was hypothesized that due to the lower abundance of these repressors, typically bound to the TFBS to prevent transcription initiation, a lower amount of ligand molecules is required to relieve inhibition. The opposite phenomenon was observed for the engineered activatorbased biosensor which displayed increased ligand sensitivity and dynamic range when the TF was more abundantly expressed. Following the same rationale, less ligand molecules would be required to form activating ligand/TF complexes due to higher TF abundance [158] . In a different study, the dynamic range of a malonyl-CoA-inducible FapR-based biosensor was optimized by fine-tuning the FapR expression level using the same arabinose-inducible AraC regulatory system. Interestingly, a clear discrepancy was observed between TF expression levels which were too low or too high, resulting in either no significant repression at all or unabolishable repression at any ligand concentration, respectively. The optimized biosensor, with a dynamic range delineated by this observed maximal and minimal output value, was successfully used to dynamically control the expression of a malonyl-CoA producing enzyme to mitigate potential toxicity upon overexpression [84] . Similarly, a distinct optimal transcription initiation rate, originating from a constitutive promoter library, was observed for the expression of two activators, XylS and HbpR, with regard to the increase of the dynamic range of their biosensor circuits [170] . The corresponding developed biosensors may serve as monitoring systems for environmental pollution through aromatic compound detection [170] . In another study, combinations of three plasmid backbones, with differing copy number, and two constitutive promoters, with differing transcription initiation rate, were used to determine the optimal LacI expression level to ensure the efficiency of a directed evolution strategy to create novel LacI variants [130] . The TFBS, core promoter and reporter gene were located separately from the TF gene on the host chromosome. A strong LacI promoter in combination with a low copy number plasmid was identified as optimal for screening LacI mutants demonstrating switch-like behavior at low IPTG concentrations. During screening, however, this relatively low expression level may have caused leaky expression which may have resulted in a decrease in mutational success rate. Consequently, the expression levels of several identified mutants were increased using a highcopy-number plasmid backbone resulting in a decrease in leaky expression of the reporter gene and an increase in induction ratio [130] .
Noteworthy, the necessity of an inducible TF expression system for biosensor applications may be undesirable and can easily be circumvented by introducing a constitutive promoter with the desired transcription initiation rate. Moreover, if present, the naturally occurring autoregulation mechanism of a transcriptional regulatory system may be exploited to stabilize TF expression. Such a negative feedback system can ensure that optimal TF concentration limits are not surpassed and, consequently, the distribution of TF copies among cells is tightened [10] .
Engineering at the transcription factor binding site/ promoter level
Binding of the TF to the TFBS directly influences the interaction of RNAP with the core promoter (−35 and −10 hexameric consensus boxes) through different regulatory mechanisms depending on the TF/TFBS pair used for biosensor construction (see Sect. "Transcriptional biosensors: a beginner's guide"). In parallel to TF engineering, on the DNA level, the specific nucleotide sequence of both the TFBS and the core promoter region can be altered to modulate the TF/TFBS and RNAP/core promoter interactions and, accordingly, the response curve (see Fig. 4c ) [4, 6, 19] . Furthermore, the position relative to the core promoter and other TFBS copies and the multiplicity of the TFBS, and potential competing binding sites, are essential factors in transcriptional regulation which can be engineered to tune the biosensor response curve (see Fig. 4d ) [4, 19] .
Creating custom transcription factor binding site/promoter variants
Core promoter sequences can be customized to bind RNAP at different kinetic constants to customize transcription initiation rates [3, 38, 97] . Furthermore, in a biosensor system, this RNAP binding is in itself directly influenced by TF binding on the TFBS. Similarly, customizing the TFBS sequence can change the affinity of the TF towards the TFBS and, therefore, influences the transcriptional regulation process of the biosensor. From the core promoter perspective, core promoter sequences which demonstrate low RNAP-binding rates are generally more easily repressed due to steric hindrance upon TF binding to the TFBS [89] . However, these weak promoters usually demonstrate a low maximum reporter expression. On the other hand, strong core promoters may be less efficiently repressed by TF binding [89] . From the TFBS perspective, a TFBS for which the TF demonstrates a high binding affinity is expected to require a lower amount of TF to achieve a certain level of repression in comparison with a TFBS for which the TF demonstrates only a low binding affinity [13, 14, 50, 155] . In general, targets for mutagenesis, to create novel TF and RNAP-binding affinities, range from complete intergenic regions, over specific TFBS or promoter consensus regions, to specific base-pairs to customize the response curve (see Fig. 4c ).
For instance, the response curve of a FapR-based malonyl-CoA biosensor was tuned by introducing random basepair substitutions in the −35 and −10 boxes of the core promoter and in the TFBS sequence [84] . The response curves of these biosensor variants were generally shifted vertically, demonstrating a concurrent change in both the maximum output signal and the amount of leaky expression [84] . In a similar study, the response curve of a PcaUbased biosensor was optimized for more sensitive detection of 3,4-dyhydroxybenzoate, a nylon precursor [69] . The core promoter region was randomized at small set of specific nucleotides which resulted in biosensor variants demonstrating the desired increase in dynamic range with, however, also an increase in leaky expression [69] . A different illustrative study aimed at the development of a set of orthogonal anhydrotetracycline (aTc)-responsive TetR biosensor pairs [141] . First, TF sequences were obtained from different prokaryotic genomes based both on TetR homology and reported regulatory functionality without prior knowledge on their corresponding native TFBSs [117] . Therefore, synthetic TFBS libraries were designed based on the characteristics of known TFBSs of TetR homologues, followed by in vitro consensus analysis and, subsequently, in vivo selection of the TFBSs for which the highest dynamic range was observed [160] . By identifying possible cross reactions of the newly obtained TF/TFBS pair library, 16 pairs were identified which can be used orthogonally for genetic circuit building [141] . Although the scope of this study was to screen for novel orthogonal TF/TFBS pairs, this workflow can also be applied directly to tune response curves by changing the TFBS sequence and position for both reported as putative TFs in a highthroughput manner.
A combination of TF engineering and TFBS engineering was used to construct novel TF-TFBS pairs with altered TFBS-binding specificity and affinity [40] . Based on comparative genomics analysis [121] , three amino-acid positions in the DBD of the cAMP receptor protein (CRP) were mutated to create eight CRP variants. The eight predicted cognate TFBSs were created by mutating the three nucleotides in each half-site of the corresponding palindromic TFBS which were predicted to interact with the DBD. Four out of eight TF-TFBS pairs were able to activate expression of the reporter gene with one of them only showing weak activation. In addition, by randomly mutating the six central nucleotides in the corresponding TFBS, the dynamic range was increased [40] .
Finally, core promoter/TFBS engineering can be applied for the adaptation of native and non-native biosensor machinery to more orthogonal and more compatible biosensor variants, respectively, with respect to the host organism of choice. As an example, the introduction of the TF gene and complete intergenic region from an Acinetobacter sp. in E. coli resulted in an impracticable signal-to-noise ratio for biosensor application [69] . This problem was partially resolved by introducing E. coli consensus RBS, −35 and −10 box sequences. However, the introduction of the consensus core promoter boxes likely generated a more constitutive promoter resulting in an increase in leaky expression of the biosensor [69] .
Tuning position and multiplicity of transcription factor binding sites…
The position of a TFBS relative to the core promoter has a direct influence on the transcriptional regulatory mechanism of a biosensor. As discussed previously (see Sect. "Transcriptional biosensors: a beginner's guide"), also the relative position on the DNA helix of the TFBS relative the core promoter sequence influences the response of some regulatory mechanisms [8, 62] . Consequently, the modulation of the relative TFBS position directly influences the mechanistic interplay of the TF, TFBS, RNAP and core promoter and, therefore, the response curve characteristics (see Fig. 4d ). Interestingly, when a TF is located away from its natural locations by placing the TFBS at different positions, other regulatory mechanisms might come into play [50, 107, 108, 126] . This dynamic interplay becomes even more complex when the TF of interest interacts with additional TF copies to regulate transcription. This di-or oligomerization implies cooperative binding and the presence of multiple TFBSs which in itself provides new engineering opportunities. As such, varying the number of TFBSs and their relative position to one another can be used to tune the biosensor response curve (see Fig. 4d ).
For instance, when increasing the sequence length of the spacer between the core promoter and the TFBS, local optima, alternated with local minima, of efficient transcriptional regulation are observed at spacer length intervals corresponding to complete helical turns (10.5 nt) [8, 16, 43, 62, 100] . This phenomenon was observed for both the dimeric AraC TF and the tetrameric LacI TF which cooperatively interact with multiple TFBSs to form a DNA loop [9, 16, 43, 79, 100] . The introduction of complete helical turns between the two TFBSs responsible for DNA looping preserves repressibility, while half-integral turns cause hindered repression. In the latter situation, the bound TFs are probably located at opposite sides of the DNA helix which prevents DNA looping and, therefore, efficient repression [9, 16, 43, 79, 100] . Interestingly, DNA looping of a regulatory circuit also enhances and stabilizes repression levels with respect to changing TF expression levels [155] . Simple repression through steric hindrance is also influenced by the (helical) position of the TFBS relative to the core promoter region [50, 76] . The position of the single TFBS of a LacI-based simple repression system was varied upstream with single base-pair resolution to investigate the effects on repression [50] . Similarly, the helical period of the DNA helix recurred in the interval between the local repression optima [50] .
In another study, various response curves were generated for an aTc/TetR-based repressive system by combinatorially varying the number and position of the corresponding single TFBS [101] . Seven core promoter/TFBS combinations were constructed with one, two or three TFBS copies and differing TFBS spacer length. In addition, a computational model was developed to predict response curves and output signal noise depending on the position and multiplicity of identical TFBSs with decreasing predictability for an increasing number of TFBSs. For the single copy TFBS circuits, leaky expression increased, concurrent with a decrease in the slope of response curve, as the TFBS is located further away from the core promoter region. Furthermore, the constructed triple copy TFBS circuit demonstrated a lower amount of leaky expression in comparison with any other tested circuit. The generation of noise in the output signal seemed to increase as the TFBS was located more proximally to the core promoter region which was likely related to the corresponding change in leaky expression [101] . Although the study of this prokaryotic transcriptional regulation system was performed in the eukaryote Saccharomyces cerevisiae, the collected information should, to a certain extent, be transferable to prokaryotic systems because of the straight-forward nature of this steric hindrance mechanism for repression.
In parallel with the previously discussed modulation of TF expression levels, the availability of TFs for transcriptional regulation can be controlled by the introduction of multiple copies of alternative TFBSs located on, e.g., several plasmid copies. These competing TFBSs, or decoys, can bind the corresponding TF to modulate the TF/TFBS ratio of the biosensor circuit and, consequently, alter the response curve. In addition, this concept reflects the fact that even in nature, for some TFs, the number of corresponding chromosomal TFBSs could be large enough for TF titration [128] .
To illustrate, a high-copy number plasmid, containing a LacI binding site, was used to titrate away available LacI TFs from a repressed gene of interest [162] . More specifically, the expression of an antibiotic resistance gene, under control of LacI repression, could be effectively induced by transforming the strain with said high-copy number plasmid, instead of supplementing IPTG. This approach enables the selection of plasmids which only contain a LacI TFBS and makes the use of resistance genes obsolete [162] . Similarly, the effect of plasmid copy number on repression was observed for the aTc/TetR repression system while maintaining a constant TF expression level [89] . Different plasmids with varying copy number were compared which contained the core promoter, TFBS and reporter gene. Here, TetR repression was less efficient for high-copy number plasmids in comparison with low copy number plasmids probably due to the changed TF/TFBS ratio as well as a decoy effect of an increase in unspecific binding sites [89] . In a more recent study, the simple LacI repression system was studied, independent of IPTG induction, with the aim of examining the interplay between the number of TFs and the number of corresponding and competing TFBSs [18] . The LacI repressor was put under control of the aTc/TetR regulatory system to adjust its intracellular expression level and regulated, in turn, the transcription initiation rate of a fluorescent protein. The copy number of the TFBSs, relative to the expression level of the TF, was altered ranging from single to high-copy numbers, with the latter generated by multiple chromosomal integrations or high-copy number plasmids. In addition, competitor TFBSs were introduced on plasmids, which did not contain a reporter gene to express. Interestingly, when the TF was distributed among an abundance of multiple TFBSs, the effect of an increase in TF copies had no significant effect on the repression of the reporter protein. When the amount of available TFs exceeded the TFBS copy number, this effect switched to a more normal, single copy-like response. The abrupt, or switch-like, nature of this phenomenon is largely dependent on the affinity the TF demonstrates for the TFBS, in addition to the distribution width of the plasmid copy number among cells. Furthermore, a thermodynamic model was constructed which enables the prediction for any such TFBS/TF configurations [18] . In a parallel study, a mechanistic model was developed, describing the effects of TF titration on reporter expression levels for simple repression systems and repression systems with DNA looping [128] . Finally, the effect of chromosomal gene location of the TFBS, core promoter and reporter gene parts of the LacI repression system was investigated while conserving the location of the LacI gene [15] . The IPTG-response curves systematically shifted vertically, without a change in the response curve slope, to lower expression levels with increasing distance from the origin. This effect was proven to be independent of the relative distance between LacI and its TFBS and was mainly the result of differences in gene copy number in relation to the chromosomal gene location. This effect can be exploited to predictably tune the response curve for chromosomal located biosensor machinery [15] .
Engineering the global biosensor architecture
Besides aforementioned engineering strategies targeting the TF or TFBS (see Sects. "Engineering biosensor ligand specificity" and "Engineering the biosensor response curve"), several other strategies might be used to tune a biosensor's response curve [4, 6, 19, 115] . Instead of focusing on the underlying transcriptional regulatory system, such strategies can target the global biosensor architecture to engineer the response curve. To this end, the ligand input levels and reporter output levels can be tuned, in addition to the construction of a cascaded biosensor by introducing additional regulatory systems in series [64, 104, 115, 157, 170] . These techniques can generally be applied independent of the chosen TF/TFBS pair and, consequently, are more easily transferable to other biosensor designs and can be used to engineering multiple distinctive biosensor designs in parallel [115] .
Engineering the ligand input level
The operational range can be tuned by modifying the amount of ligand molecules which are effectively detected by the biosensor. If the intracellular concentration of the ligand molecule is decreased by the expression of an exporter protein, the operational range of the biosensor can be shifted to higher ligand concentrations [115] . Likely, the opposite can be achieved by the expression of an importer protein. For example, the operational range of the aTc/ TetR-based regulatory circuit was shifted tenfold higher for both the lower and upper ligand concentration limit by expressing the aTc exporter protein, TetA. In addition, this operational shift could be customized by tuning the expression of this exporter with the arabinose/AraC-based regulatory system [115] .
Engineering the reporter output level
The dynamic range is determined by the mRNA output, which is, for example, translated into a fluorescent protein, in proportion to the ligand input. This output level can be modulated by changing, e.g., the mRNA stability, the translation (initiation) rate and the protein degradation rate to change the response curve without interference of the transcriptional regulatory circuit of the biosensor. These concepts are reviewed in more detail elsewhere [4, 6, 19, 113] . For example, the translation initiation rate of the fluorescent reporter protein was varied to customize the response curve of an HbpR-based biosensor for aromatic compound detection [170] . More specifically, a library of predefined RBS sequences with reported relative strengths was introduced and the resulting response curves analyzed. This approach enabled the increase of the dynamic range of the biosensor without directly altering the cognate TF/TFBS regulatory system [170] . In a similar effort, the RBS strength was varied to modulate selector expression levels and, consequently, the evolutionary escape rate of a TtgR-based naringenin biosensor [26, 115] . This biosensor was successfully applied for toggled selection during an iterative genomewide mutagenesis approach to increase naringenin production [115] . Besides improving the translation initiation rate of an output protein, the degradation of said protein can be modulated by adding different proteolytic tags to the output protein [4, 6, 115] . This approach was validated by appending different degradation tags to the selector output protein of a naringenin biosensor to reduce the evolutionary escape rate during a genome-wide directed evolution approach for optimizing microbial naringenin production. As the degradation rates increased with differing tags, the evolutionary escape rate was reduced with, however, also a reduction in operational range [115] .
Biosensor cascades
A biosensor response curve can also be tuned by creating a linear single input/single output biosensor cascade which contains one or more additional TF/TFBS pairs in series. The development of such a cascaded biosensor enables inversion of the input/output relation, tunable and fixedgain amplification of the output signal and modulation of response times, among others [64, 104, 127, 145, 157] .
As an example, the aTc/TetR-based regulatory circuit was expanded with up to two extra TF/TFBS pairs each regulating TF expression of the subsequent link in the biosensor cascade [64] . Here, the increase in cascade length directly altered the operational and dynamic range, with a clear increase in sensitivity and decrease of the half-maximal threshold as a result. However, a downside of this approach was observed with regard to cell-cell variability and response delay time which both increased as the cascade length increased [64] . In a different study, a feedback-based amplifier was successfully developed for a single input/single output biosensor circuit [104] . More specifically, a constitutively active, ligand-independent variant of the LuxR repressor was used as input of an amplifier circuit to regulate the transcription initiation rates of both a fluorescent reporter protein and the LuxR variant itself. The output signal of the aTc/TetR-based biosensor was amplified by putting an additional copy of the LuxR variant gene under control of the TetR repressor and co-transforming the amplifier circuit on a separate plasmid into the biosensor host. When the ligand, aTc, is supplemented, TetR repression is inhibited and transcription of the LuxR gene variant is initiated. Subsequently, this LuxR variant initiates transcription of the fluorescent protein gene and the additional LuxR variant gene expression which acts as the amplifier by initiating transcription even more. This amplifier circuit increased the maximum output signal, the operational range, and sensitivity of the biosensor response curve [104] . A different approach was used by Wang and coworkers to develop both a fixed-gain and a tunable-gain amplifier circuit which can be integrated in a biosensor circuit [157] . Here, a set of two complexing ultrasensitive, ligand-independent activator proteins were introduced as the direct output of an arsenic-responsive ArsR-based biosensor to regulate the expression of a fluorescent reporter gene in the next chain of the cascade. This fixed-gain amplifier circuit increased the dynamic range as well as the ligand sensitivity of the biosensor response curve. A tunable variant of this circuit was constructed by introducing an arabinose/AraC-based circuit which controlled the transcription initiation rate of a third protein which inhibits the formation of the activating complex of the other two proteins in the amplifier circuit. Noteworthy, no apparent increase in response delay time or noise was observed when implementing these amplifier circuits [157] . Finally, a set of 15 "sensitivity tuners" were developed based on phage-derived TF-TFBS pairs which can be put in series into a biosensor circuit of choice. These circuits were able to increase the maximal output signal and slope of the arabinose/AraC-based biosensor [4, 177] .
Conclusions and perspectives
Metabolism heavily relies on transcriptional regulatory systems to optimally control cellular processes with a view to optimal performance under a wide range of environmental conditions. These regulatory systems are ideal starting points for the development of biosensors for industrial biotechnology applications to dynamically control de novo assembled pathways and to screen combinatorial microbial cell factory libraries, among others. In this respect, in view of the ever increasing set of biotechnologically produced molecules and despite the already comprehensive transcription factor libraries, the further discovery of novel ligands, transcription factors and binding sites through part mining from nature will spark future applications when exploiting the next-generation sequencing tools and extensive computational methods.
However, the operational and dynamic ranges and ligand specificity of such natural biosensors typically do not fully align with the strict requirements of specific applications, e.g., the operational range of natural biosensor is generally too low for screening libraries of excessive producers. Hence, extensive tuning of the biosensor's main characteristics is of utmost importance. To this end, various techniques ranging from full-blown mutagenesis to computer-aided design and ranging from fluorescence-activated cell sorting to kinetic characterization have successfully been applied whereby novel ligand specificities and/ or the dynamic and operational range have been drastically altered.
Nevertheless, despite numerous success stories in reengineering the transcriptional biosensors' main characteristics, true incremental knowledge acquisition is limited due the incredibly large number of parameters defining both the specificity and the dose response curve. Consequently, many engineering efforts have thus far relied on mostly ad hoc engineering strategies with limited predictability and scarce opportunities for true standardization. To streamline the development process of novel biosensors, the advancement of a holistic computational framework that considers the various interactions of different nature will be of utmost importance. Undoubtedly, this will accelerate the biosensor development process, which is of great interest for metabolic engineering and will enable industrial biotechnology to generate more efficient and faster microbial cell factories for an expanding collection of natural and non-natural molecules.
